Nomura Holdings’s iHuman IH Stock Holding History

Nomura Holdings’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-55,400	Closed	-$630K	–	2164
2021 Q1	$630K	Hold	55,400	–	–	﹤0.01%	1270
2020 Q4	$1.02M	Buy	+55,400	New	+$1.23M	﹤0.01%	1028

Other funds holding IH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Nomura Holdings's IH Position: Q2 2021 in Review

Nomura Holdings sold out of iHuman (IH) in Q2 2021, closing a stake of 55,400 shares — an estimated $630K sold.

Nomura Holdings first reported a position in IH in Q4 2020 and held it in 2 quarters. The position peaked at $1.02M in Q4 2020. 9 funds tracked by Wall St. Rank hold IH as of Q2 2021.

Nomura Holdings reported no remaining iHuman position as of Q2 2021 after selling out during the quarter.
Nomura Holdings sold 55,400 iHuman shares in Q2 2021, an estimated $630K.
Nomura Holdings first reported a position in iHuman in Q4 2020 and held it in 2 quarters.
Nomura Holdings's iHuman position peaked at $1.02M in Q4 2020.
9 funds tracked by Wall St. Rank held iHuman as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.